| Peptide therapeutics: current status and future directions K Fosgerau, T Hoffmann Drug discovery today 20 (1), 122-128, 2015 | 3054 | 2015 |
| Mouse models of nonalcoholic steatohepatitis in preclinical drug development HH Hansen, M Feigh, SS Veidal, KT Rigbolt, N Vrang, K Fosgerau Drug discovery today 22 (11), 1707-1718, 2017 | 244 | 2017 |
| Astrocyte glycogen sustains neuronal activity during hypoglycemia: studies with the glycogen phosphorylase inhibitor CP-316,819 ([RR*, S*]-5-chloro-N-[2-hydroxy-3 … SW Suh, JP Bergher, CM Anderson, JL Treadway, K Fosgerau, ... Journal of Pharmacology and Experimental Therapeutics 321 (1), 45-50, 2007 | 235 | 2007 |
| Astrocyte glycogen metabolism is required for neural activity during aglycemia or intense stimulation in mouse white matter AM Brown, HM Sickmann, K Fosgerau, TM Lund, A Schousboe, ... Journal of neuroscience research 79 (1‐2), 74-80, 2005 | 198 | 2005 |
| Long-term characterization of the diet-induced obese and diet-resistant rat model: a polygenetic rat model mimicking the human obesity syndrome AN Madsen, G Hansen, SJ Paulsen, K Lykkegaard, M Tang-Christensen, ... Journal of Endocrinology 206 (3), 287, 2010 | 185 | 2010 |
| Glucagon receptor knockout mice display increased insulin sensitivity and impaired β-cell function H Sørensen, MS Winzell, CL Brand, K Fosgerau, RW Gelling, E Nishimura, ... Diabetes 55 (12), 3463-3469, 2006 | 135 | 2006 |
| Kinetic and functional characterization of 1, 4-dideoxy-1, 4-imino-d-arabinitol: a potent inhibitor of glycogen phosphorylase with anti-hyperglyceamic effect in ob/ob mice K Fosgerau, N Westergaard, B Quistorff, N Grunnet, M Kristiansen, ... Archives of biochemistry and biophysics 380 (2), 274-284, 2000 | 129 | 2000 |
| Characterisation of age-dependent beta cell dynamics in the male db/db mice LS Dalbøge, DLC Almholt, TSR Neerup, E Vassiliadis, N Vrang, ... PloS one 8 (12), e82813, 2013 | 108 | 2013 |
| Immunoneutralization of endogenous glucagon reduces hepatic glucose output and improves long-term glycemic control in diabetic ob/ob mice H Sørensen, CL Brand, S Neschen, JJ Holst, K Fosgerau, E Nishimura, ... Diabetes 55 (10), 2843-2848, 2006 | 104 | 2006 |
| The novel GLP‐1‐gastrin dual agonist, ZP3022, increases β‐cell mass and prevents diabetes in db/db mice K Fosgerau, L Jessen, J Lind Tolborg, T Østerlund, K Schaeffer Larsen, ... Diabetes, Obesity and Metabolism 15 (1), 62-71, 2013 | 99 | 2013 |
| Compartmentation of lactate originating from glycogen and glucose in cultured astrocytes HM Sickmann, A Schousboe, K Fosgerau, HS Waagepetersen Neurochemical research 30, 1295-1304, 2005 | 72 | 2005 |
| Drug-induced mild therapeutic hypothermia obtained by administration of a transient receptor potential vanilloid type 1 agonist K Fosgerau, UJ Weber, JW Gotfredsen, M Jayatissa, C Buus, ... BMC cardiovascular disorders 10, 1-10, 2010 | 53 | 2010 |
| 40th EASD Annual Meeting of the European Association for the Study of Diabetes: Munich, Germany, 5–9 September 2004 M Veitenhansl, K Stegner, FX Hierl, C Dieterle, H Feldmeier, B Gutt, ... Diabetologia 47, A1-A464, 2004 | 51 | 2004 |
| Treatment of cardiac conditions JS Petersen, AL Kjoelbye, M Skovgaard, HD Pedersen, L Axelsen, ... US Patent App. 13/574,197, 2013 | 44 | 2013 |
| Novel GLP-1/GLP-2 co-agonists display marked effects on gut volume and improves glycemic control in mice P Wismann, SL Pedersen, G Hansen, K Mannerstedt, PJ Pedersen, ... Physiology & behavior 192, 72-81, 2018 | 39 | 2018 |
| The novel GLP-1–gastrin dual agonist ZP3022 improves glucose homeostasis and increases β-cell mass without affecting islet number in db/db mice LS Dalbøge, DLC Almholt, TSR Neerup, N Vrang, J Jelsing, K Fosgerau Journal of Pharmacology and Experimental Therapeutics 350 (2), 353-360, 2014 | 39 | 2014 |
| Glucagon analogues JL Tolborg, K Fosgerau, P Nørregaard, R Just, D Riber, DW Hamprecht, ... US Patent 9,180,169, 2015 | 38 | 2015 |
| Interleukin-6 autoantibodies are involved in the pathogenesis of a subset of type 2 diabetes K Fosgerau, P Galle, T Hansen, A Albrechtsen, CL Rieper, BK Pedersen, ... Journal of endocrinology 204 (3), 265, 2010 | 34 | 2010 |
| The anti-diabetic effects of GLP-1-gastrin dual agonist ZP3022 in ZDF rats J Skarbaliene, T Secher, J Jelsing, TSR Neerup, N Billestrup, K Fosgerau Peptides 69, 47-55, 2015 | 30 | 2015 |
| Novel α-MSH analog causes weight loss in obese rats and minipigs and improves insulin sensitivity K Fosgerau, K Raun, C Nilsson, K Dahl, BS Wulff The Journal of Endocrinology 220 (2), 97, 2014 | 30 | 2014 |
Helle WaagepetersenProfessor, Københavns UniversitetVerificeret mail på sund.ku.dk
